Reduced Renal Mass, Salt-Sensitive Hypertension Is Resistant to Renal Denervation

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Hypertension Research

Background:

• Sympathetic nervous system activation is common in resistant hypertension (RHT) and chronic kidney disease (CKD).
• Renal denervation (RDNx) is a potential treatment for RHT, but its efficacy varies.
• The impact of reduced nephron mass on RDNx response is not well understood.

Purpose of the Study:

• To investigate the effect of nephron loss on the antihypertensive response to RDNx.
• To determine if RDNx provides a sustained blood pressure reduction in a model of salt-sensitive hypertension with significant nephron loss.

Main Methods:

• Systemic hemodynamics and blood pressure oscillations were measured in rats.
• Surgical reduction of renal mass (approximately 80%) was performed.
• RDNx was conducted on the remnant kidney, followed by high salt diet and clonidine administration.

Main Results:

• Reduced renal mass followed by a high salt diet induced sustained hypertension and suppressed sympathetic activity.
• RDNx temporarily lowered arterial pressure, increased sympathetic activity and heart rate, but these effects were not sustained.
• Clonidine administration did not alter arterial pressure in this model.

Conclusions:

• RDNx does not provide chronic blood pressure lowering in salt-sensitive hypertension with substantial nephron loss.
• These findings offer insights into factors influencing RDNx efficacy in CKD patients.
• The absence of sustained response suggests that conditions like nephron loss may limit the benefits of renal sympathoinhibition.